April 2014 Newsletter

April 16, 2014:

What’s in Store at the 2014 ASCRS Meeting

A look at the hot topics expected to dominate this year’s conference in Boston.

April 16, 2014:

Our Cutout Page of Must-see Sessions at the 2014 ASCRS

This page is available to everyone for download.

April 16, 2014:

US IOL Procedures Climb 4.1 Percent in Q4 and 3.7 Percent for Full Year 2013

Doctors performed more than 3.7 million implantations in 2013.

April 16, 2014:

Ophthalmologists Defend High Payments After Release of Medicare Physician Data

News coverage scrutinized payments of nearly $1 billion for Lucentis treatments for patients with retinal disease.

April 16, 2014:

IOL Workshop by FDA and AAO Debates Performance Measurements for Premium Lenses

The meeting was designed to identify challenges in lens innovation.

April 16, 2014:

Europe Moves Closer to Full Data Disclosure for Clinical Trials

New rules include the creation of a publicly accessible database of all results.

April 16, 2014:

ThromboGenics Plans Large Postmarket Studies to Yield More Data and Boost Use of Jetrea

Clinical trials will further evaluate the efficacy and safety of the vitreolytic.

April 16, 2014:

Q4-2013 US Refractive Surgery Volumes Fall for Fifth Consecutive Quarter

Market is somewhat out of step with generally improving economic conditions.

April 16, 2014:

Global Demand for Refractive Surgery Growing, Despite Declines in Some Key Markets

Annual procedure volume expected to increase from 3.4 million to 4.3 million.

April 16, 2014:

Novartis Appoints New Leader for Alcon Business

Jeff George will be the sixth executive to lead Alcon in its almost 70-year history.

April 16, 2014:

Latest ‘Doc Fix’ Delays Cuts in Medicare Payments for a Year

The 12-month patch will extend the current 0.5 percent increase through 2014.

April 16, 2014:

New Deadline for ICD-10 Coding In Flux

Legislation that delays implementation contains vague wording for new start date.

April 16, 2014:

April 2014 News Briefs

Social media